Id-KLH Vaccine

DRUG2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

B Cell LymphomaFollicular LymphomaLymphomaNeoplasm

Phase 1

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

CompletedNCT00001572

National Cancer Institute (NCI)B Cell Lymphoma, Follicular Lymphoma, Neoplasm

Start: 1997-01-30End: 2010-11-02Updated: 2017-07-02

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

CompletedNCT00001512

National Cancer Institute (NCI)B Cell Lymphoma, Follicular Lymphoma, Lymphoma

Start: 1996-09-09End: 2010-03-05Updated: 2017-07-02